February, 2026 - Microbiome Times Magazine

Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis

February 11, 2026 Microbiome Times

Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces positive results in its Phase 1b First-in-Human trial, COMPOSER-1, of MB310 in ulcerative colitis (UC) patients. […]